RNTX

Rein Therapeutics, Inc. Common Stock
RNTX

Overview Fund Activity

23 hedge funds and large institutions have $1.15M invested in Rein Therapeutics, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 6 closing their positions.

Holders
23
Holders Change
–
Holders Change %
0%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
7
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$169K
2
Deutsche Bank
2
Deutsche Bank
Germany
$108K
3
HBWM
3
Hollow Brook Wealth Management
New York
$25K
4
Citadel Advisors
4
Citadel Advisors
Florida
$17K
5
TSS
5
Two Sigma Securities
New York
$9K

Top Sellers

1
BCM
1
Bridgeway Capital Management
Texas
$0
2
SLF
2
Sun Life Financial
Ontario, Canada
$0
3
Jacobs Levy Equity Management
3
Jacobs Levy Equity Management
New Jersey
$0
4
AAP
4
Ardsley Advisory Partners
Connecticut
$0
5
ECM
5
Element Capital Management
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
UBS Group
26
UBS Group
Switzerland
– – -4,367 Closed
WVP
27
Worth Venture Partners
New Jersey
– – – –
FHA
28
Flagship Harbor Advisors
Massachusetts
$0 500 – –
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
$0 14 – –
CFGS
30
Concourse Financial Group Securities
Alabama
– – – –
AG
31
Advisor Group
Arizona
$0 150 – –
1
2